| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/04/2002 | WO2001063282A3 Analysis of biological targets using a biochip comprising a fluorescent marker |
| 04/04/2002 | WO2001062792A3 Cancer treatment and prognosis involving hes-1 protein |
| 04/04/2002 | WO2001062778A3 Tumour-specific animal proteins |
| 04/04/2002 | WO2001061305A3 Immunoassays detecting or making use of at least two rubber latexallergens |
| 04/04/2002 | WO2001060350A3 Method for identifying and using a2b adenosine receptor antagonists to mediate mammalian cell proliferation |
| 04/04/2002 | WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 04/04/2002 | WO2001054813A3 Devices and methods for biochip multiplexing |
| 04/04/2002 | WO2001053607A3 Method for manufacturing concrete |
| 04/04/2002 | WO2001053352A3 Sperm specific proteins |
| 04/04/2002 | WO2001042490A3 Novel alizarin-based chromogenic substrates |
| 04/04/2002 | WO2001036963A3 Method for detecting noxious substances using plant cell suspensions |
| 04/04/2002 | WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 04/04/2002 | WO2001032694A3 Method for characterising and separating molecular associates |
| 04/04/2002 | WO2001030390A3 Method |
| 04/04/2002 | WO2001016361A3 Method for detecting and quantifying first biopolymers that are located in a liquid |
| 04/04/2002 | WO2000072021A3 Cancer associated antigens and uses therefor |
| 04/04/2002 | WO2000070099A3 Differential gene expression in specific regions of the brain in neurodegenerative diseases |
| 04/04/2002 | WO2000061808A9 Methods for detecting nucleic acids indicative of cancer |
| 04/04/2002 | US20020040489 Expressed sequences of arabidopsis thaliana |
| 04/04/2002 | US20020040488 Synthases |
| 04/04/2002 | US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2 |
| 04/04/2002 | US20020040483 Contacting a test compound to a nematode; and monitoring a female sexual maturation of the nematode, wherein inhibition of the female sexual maturation indicates that the test compound includes the anti-nematode agent |
| 04/04/2002 | US20020040277 Particle analyzer and particle classifying method |
| 04/04/2002 | US20020040276 Accessibility correction factors for electronic models of cytochrome P450 metabolism |
| 04/04/2002 | US20020040275 Proteomic analysis |
| 04/04/2002 | US20020040216 Cell storage maintenance and monitoring system |
| 04/04/2002 | US20020040196 Dual riser/single capillary viscometer |
| 04/04/2002 | US20020040132 Using one or more agonists and/or antagonists of the G protein coupled receptor GPR56 as test compounds in one or more appetite control test procedures, and selecting an active compound for use as an appetite control agent |
| 04/04/2002 | US20020040130 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 04/04/2002 | US20020040059 Controlling cancer by reducing its growth and improving response to therapy |
| 04/04/2002 | US20020040009 Novel ratA |
| 04/04/2002 | US20020040000 Human kcnq5 potassium channel, methods and compositions thereof |
| 04/04/2002 | US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | US20020039797 Apparatus for use as diagnostic tool in drug screening |
| 04/04/2002 | US20020039796 Device and method for cytology slide preparation |
| 04/04/2002 | US20020039795 Method of preparing delta-9-tetrahydrocannabinol |
| 04/04/2002 | US20020039793 Quantitative, qualitative analysis |
| 04/04/2002 | US20020039776 Mammalian SUV39H2 proteins and isolated DNA molecules encoding them |
| 04/04/2002 | US20020039774 Anticholesterol agents |
| 04/04/2002 | US20020039763 Interferon-like protein Zcyto21 |
| 04/04/2002 | US20020039757 Enzyme method for detecting lysophospholipids and phospholipids and for detecting and correlating conditions associated with altered levels of lysophospholipids |
| 04/04/2002 | US20020039756 Evaluation and classification of toxicity in humans; obtain samples, incubate with antibodies, detect bound complexes, increased concentration of bound complexes indicates toxicity in humans |
| 04/04/2002 | US20020039755 Conjugate vaccine against gram-negative bacterial infections |
| 04/04/2002 | US20020039754 Monitoring and classifying the spread of cancer in humans; obtain biopsy of tissue, determine concentration of tumor suppressor protein, determine thrombospondin concentration, monitor vascularization, evaluate cell for tumor propagation |
| 04/04/2002 | US20020039753 Method of identifying and treating invasive carcinomas |
| 04/04/2002 | US20020039752 Monitoring treatment of preferential psychological disorder; obtain membranes, detect adjustment in membrane or cytoskeletal cells, monitor activities of human |
| 04/04/2002 | US20020039751 High throughput screening assay systems in microscale fluidic devices |
| 04/04/2002 | US20020039750 Method and device for increasing efficiency of bioanalysis |
| 04/04/2002 | US20020039747 Protein separation; genetic mapping |
| 04/04/2002 | US20020039746 Methods for identifying peripheral benzodiazepine receptor binding agents |
| 04/04/2002 | US20020039742 Staining solid carrier with Dna and detector zones; incubation, electrostatic bonding |
| 04/04/2002 | US20020039740 Accurately determining binding association on microarrays of genomic samples; obtain samples, measure binding associations, compare to control, determine accracy of measurements |
| 04/04/2002 | US20020039737 Determining velocity of elongated biopolymer; classify segment of biopolymer, transfer biopolymer through detection zones, monitor signal amplitude, measure signal amplitude profiles, analyze signal to determine biopolymer velocity |
| 04/04/2002 | US20020039736 Reacting aliphatic aminonitrile with water in presence of solid alumina catalyst to form lactam |
| 04/04/2002 | US20020039734 Detecting preferential lymphocytes in sample; obtain lymphocyte, compare concentration of markers with wild type, adjustment in concentration of markers indicates presence of helper lymphocytes |
| 04/04/2002 | US20020039732 Amplification; hybridization |
| 04/04/2002 | US20020039725 Fish hatching method and apparatus |
| 04/04/2002 | US20020039723 Biocatalytic methods for synthesizing and identifying biologically active compounds |
| 04/04/2002 | US20020039599 Calibration; administering antiseptic compound |
| 04/04/2002 | US20020039186 Optical probes and methods for spectral analysis |
| 04/04/2002 | US20020038571 Water-monitoring apparatus capable of auto-tracing water level and non-contact signal relay for the same |
| 04/04/2002 | US20020038516 Hole center detecting apparatus, straightness measuring apparatus, and residual torsion measuring apparatus |
| 04/04/2002 | DE10057396C1 Separation of e.g. biomolecules from dispersion or solution, employs magnetic particles onto which substance is sorbed, and electromagnet for their extraction |
| 04/04/2002 | DE10047422C1 Process for monitoring water surfaces for impurities such as oil comprises illuminating the water surface with a headlight via a reflecting wall, recording the colors reflected, and identifying the impurities using a monitor |
| 04/04/2002 | DE10046215A1 Fluorochrome und deren Verwendung Fluorochromes and their use |
| 04/04/2002 | DE10044491A1 Density measurement equipment for gas charged, pressurized fluid plastic comprises pressure sensor, density measuring cell and control unit to determine fluid density under standard conditions |
| 04/04/2002 | DE10034647C1 Verfahren zur Durchführung einer Speichelanalyse A method for performing analysis of saliva |
| 04/04/2002 | CA2426655A1 Method and device for making a support bearing a plurality of different polynucleotide and/or peptide sequences |
| 04/04/2002 | CA2424039A1 Quantitative digital fluorography and related products and methods |
| 04/04/2002 | CA2424031A1 System and process for validating, aligning and reordering genetic sequence maps using ordered restriction map |
| 04/04/2002 | CA2423991A1 Pumpcn compositions and uses thereof |
| 04/04/2002 | CA2423955A1 Kini-3 motor protein and methods for its use |
| 04/04/2002 | CA2423953A1 Hydrolases |
| 04/04/2002 | CA2423924A1 High density arrays |
| 04/04/2002 | CA2423922A1 Reagents, method and kit for detecting phosphinothricin-n-acetyltransferase protein |
| 04/04/2002 | CA2423889A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | CA2423879A1 Method of screening for therapeutics for infectious diseases |
| 04/04/2002 | CA2423822A1 Method for immobilising lipid layers |
| 04/04/2002 | CA2423797A1 Antibodies to the propeptide of candida albicans and methods of use |
| 04/04/2002 | CA2423704A1 G-protein coupled receptors |
| 04/04/2002 | CA2423701A1 Oxidoreductases |
| 04/04/2002 | CA2423694A1 Transferases |
| 04/04/2002 | CA2423668A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | CA2423613A1 Transgenic drosophilia melanogaster expressing beta amyloid |
| 04/04/2002 | CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 04/04/2002 | CA2423424A1 Secreted proteins |
| 04/04/2002 | CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | CA2422890A1 Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents |
| 04/04/2002 | CA2422530A1 Human drug metabolizing enzymes |
| 04/04/2002 | CA2422099A1 Identification of neuroblastoma tumor suppressor genes |
| 04/04/2002 | CA2421933A1 Assays for identifying receptors having alterations in signaling |
| 04/04/2002 | CA2421680A1 Antibodies for human cytochrome p450 2d6 |
| 04/04/2002 | CA2420960A1 Potassium channel interactors and uses therefor |
| 04/04/2002 | CA2420475A1 Ige receptor antagonists |
| 04/04/2002 | CA2420415A1 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome |
| 04/04/2002 | CA2392213A1 Method for early prediction of the onset of invasive cancer |
| 04/03/2002 | EP1193499A1 Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device |
| 04/03/2002 | EP1193498A2 Test rig and particulate deposit and cleaning evaluation processes using the same |
| 04/03/2002 | EP1193494A1 Body fat determining device |
| 04/03/2002 | EP1193488A1 Method and device for determining the gaseous quality of natural gas |